Elevance (ELV) stock thrives with fee-based plans, preventive care, and disciplined capital management, ensuring growth and strong investor returns. See more.

Truist Financial raised its price target on Elevance Health from $480 to $510, flashing a strong "buy" signal. Several analysts, including Barclays and Bernstein, echoed optimism with ratings ranging ...